Assessment of antihypertensive effect by blood pressure monitoring: Applications to bisoprolol and lisinopril in a double-blind study

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 5, 1997, Pages 612-617

  Vaisse B ^a   Herpin, D ^b   Asmar, R ^c   Battistella, P ^d   Zannad, F ^e   Boutelant, S ^f   Lyon, A ^d   Conte, D ^g   Denis, J ^d   Honore, Ph ^d   Contard, S ^d   Prost, P L ^h   Mallion, J M ^f   Poggi, L ^a  

^a TIMONE HOSPITAL   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c HÔPITAL BROUSSAIS   (France)

^d CENTRE HOSPITALIER   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f CHU La Tronche and University   (France)

^g CHU PURPAN   (France)

^h Laboratoires LEDERLE   (France)

Author keywords

Ambulatory blood pressure monitoring; Antihypertensive effect; Bisoprolol; Lisinopril

Indexed keywords

BISOPROLOL; LISINOPRIL; PLACEBO;

ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; BLOOD PRESSURE MONITORING, AMBULATORY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; LISINOPRIL; MALE; MIDDLE AGED;

EID: 0343051996     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199705000-00008     Document Type: Article

References (24)

1. Conway J, Johnston J, Coasts A, Somers V, Sleight P. The use of blood pressure monitoring to improve the accuracy and reduce the number of subjects in clinical trials of antihypertensive agents. J Hypertens 1988;6:111-6.
2. Berglund G, Faire U, Castenfors J, et al. Monitoring 24 hours blood pressure in a drug trial: evaluation of a non-invasive device. Hypertension 1985;7:688-94.
3. Weber MA, Tonkon MJ, Klein RC. Blood pressure monitoring for assessing the duration of action of antihypertensive treatment. J Clin Pharmacol 1987;27:751-5.
4. Mancia G, Casadei R, Mutti E, Trazzi S, Parati G. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment. Am J Med 1989;87(suppl 6B):64-9S.
5. O'Brien E, Cox JP, O'Malley K. Ambulatory blood pressure lowering drugs. J Hypertens 1989;7:243-7.
6. Pickering TG, O'Brien E. Second International Consensus Meeting on Twenty Four Hour Ambulatory Blood Pressure Measurements: consensus and conclusions. J Hypertens 1991;9(suppl 8):25-65.
7. Rion F, Waeber B, Graf HG, Jaussi A, Porchet M, Brunner HR. Blood pressure response to antihypertensive therapy: ambulatory versus office blood pressure readings. J Hypertens 1985;3:139-43.
8. White WB, Lund-Johansen P, Omvik P. Twenty-four-hour blood pressure load as a surrogate end point in assessing antihypertensive therapy. J Hypertens 1993;11(suppl 4):S75-80.
9. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987;5:93-8.
10. White WB. Predicting hypertensive heart disease via non-invasive methodology: relationship between ambulatory blood pressure and cardiac indices derived by echocardiography and radionuclide ventriculography. J Hypertens 1990;8(suppl 6):S113-8.
11. Richard B, Devereux, Pickering TG. Relationship between the level, pattern and variability of ambulatory blood pressure and target organ damage in hypertension. J Hypertens 1991;9(suppl 8):S34-8.
12. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994;7:23-9.
13. Mann S, Millar Craig MW, Raftery ER. Superiority of 24 hour measurement of blood pressure over clinic values in determining prognosis in hypertension. Clin Exp Hypertens 1985;7:279-81.
14. Perloff D, Sokolow M, Cowan RM, Juster RP. Pronostic value of ambulatory blood pressure measurements: further analyses. J Hypertens 1989;7(suppl 3):S3-10.
15. Weber MA, Cheung DG, Graettinger WF, Lipson JL. Characterization of antihypertensive therapy by whole-day blood pressure monitoring. JAMA 1988;259:3281-5.
16. Lacourcière Y, Poirier L, Dion D, Provencher P. Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure. Am J Cardiol 1990;65:467-72.
17. Herpin D, Vaïsse B, Pitiot M, et al. A comparison of angiotensin-converting enzyme inhibitors and calcium antagonists in the treatment of mild to moderate systemic hypertension, according to baseline ambulatory blood pressure level. Am J Cardiol 1992;69:923-6.
18. Mancia G, Omboni S, Ravogli A, Parati G, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Pressure 1995;4:148-56.
19. Staessen J, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A. Reference values for ambulatory blood pressure: a meta-analysis. J Hypertens 1990;8:S57-64.
20. Oldham PD. A note on the analysis of repeated measurements of the same subjects. J Chronic Dis 1962;15:969-77.
21. Gill JS, Zezulka AV, Beevers DG, Davies P. Relation between initial blood pressure and its fall with treatment. Lancet 1985;1:567-9.
22. Myers MG, Reeves A. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991;10:844-9.
23. Ashida T, Abe H, Kawano Y, et al. Effects of nifedipine SR and enalapril on office, home and ambulatory blood pressure in "white-coat" systemic hypertension. Am J Cardiol 1990;66:498-501.
24. Fagard R, Staessen J, Thijs L, Amery A. Response of ambulatory blood pressure to antihypertensive therapy, guided by clinic pressure. Am J Hypertens 1993;6:648-53.